ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
TROP2-Targeting Chimeras (TRTACs) for Tumor Cell-Selective Membrane Protein Degradation and Enhanced Drug Delivery.
Luping Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.